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CORRESPONDENCEProphylactic Endovascular Repair of Small
Abdominal Aortic Aneurysm
We read with great interest the article by Zarins et al.1
They reviewed all patients with small abdominal aortic
aneurysm treated with a stent graft in the multicenter
AneuRx clinical trial. A subgroup of patients who met
the age and aneurysm size inclusion criteria of the UK
Small Aneurysm Trial (EVARmatch) were compared to
thepublished resultsof the surveillancepatient cohortof
theUKSmallAneurysmTrial.While EVAR trials 1 and 2
suggested endovascular repair may have no advantage
over open repair (for patients considered fit for open
repair) or no intervention (for patients of poor health
status considered unfit for open repair) with regard to
overall survival, this form of treatment has been
advocated for small abdominal aortic aneurysms.2–4
Zarins et al. made every effort to match the AneuRx
small aneurysm patient population to the inclusion
criteria of the UK Small Aneurysm Trial, but there were
important differences between the EVARmatch and UK
surveillance groups with respect to age, comorbidities
and genderdistribution. Itwould be interesting to know
morbidities, including total or fatal ruptures and
aneurysm related or all-cause deaths, adjusted for age,
comorbidities, and gender. Although we greatly
appreciate the ‘virtual’ randomized controlled trial by
Zarins et al., we strongly support an ‘actual’ trial of open
versus endoluminal repair of small aortic aneurysms.
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Endovascular Repair or Surveillance of Patient
with Small AAA
Dear Editor
We agree with Drs Takagi and Umemoto that endovas-
cular repair of small abdominal aortic aneurysms
appears to improve outcome compared to ultrasound
surveillance and that aprospective randomized trialwill
beneeded toconfirmthishypothesis.Ourcomparisonof
a matched cohort of patients with small aneurysms
treatedwithendovascular repair inaprospectiveclinical
trial to patients with small aneurysms randomized to
surveillance in the UK small aneurysm trial does not
constitute a ‘virtual’ randomized controlled trial.
However, it does provide evidence that early endovas-
cular repair of small aortic aneurysms may reduce the
risk of fatal aneurysm rupture and aneurysm-related
death and improve overall patient survival compared to
ultrasound surveillance.1
As Dr Takagi notes, there were important
differences between the EVARmatch and UK
surveillance groups with respect to age, comorbid-
ities and gender. Patients treated with EVAR were
older, had more comorbidities and had largerEur J Vasc Endovasc Surg 31, 562–563 (2006)
doi:10.1016/j.ejvs.2005.12.021, available online at http://www.sciencedirect.com on
Correspondence 563aneurysms than UK surveillance patients and these
differences would tend to balance the analysis in
favor of surveillance. On the other hand, there
were proportionately twice as many women in the
UK surveillance group and women had a four fold
higher risk of rupture in the UK experience, thus
possibly skewing the analysis in favor of EVAR.
We adjusted our analysis of fatal rupture and all-
cause mortality for differences in gender and
length of follow up and the statistically significant
differences in favor of EVAR persisted. Since the
published UK data was not stratified by gender,
age or comorbidities for the other endpoints, we
could not adjust for them.
Since the UK small aneurysm trial was focused on
all-cause mortality as the primary endpoint the
published data allowed us to stratify patients by age
groups and gender for this end-point. The overall age-
adjusted comparison of all-cause mortality revealed a
higher mortality in UKsurveillance (8.3 deaths per 100
patient years) than in EVARmatch (6.0 deaths per 100
patient years, pZ0.005). The overall gender-adjusted
comparison for all-cause mortality revealed a higher
mortality in UK surveillance (8.3 deaths per 100
patient years) than in EVARmatch (5.9 deaths per
100 patients years, pZ0.003). Thus, early endovascular
repair appears to reduce all-cause mortality in patients
with small aneurysms.
Although the prospective, randomized EVAR-1 trial
of good risk patients with aneurysms larger than 5.5 cm
did not show a survival advantage over open repair, it*Corresponding author. Christopher K. Zarins, MD, Department of
Surgery, Stanford University, 300 Pasteur Drive, H3642, Stanford, CA
94305-5642, USA.did show a significant reduction in operative mortality
and a significant reduction in AAA related death which
wasmaintained over the 4 year followupperiod.2 These
endpoints are themost relevant endpoints in evaluating
aneurysm treatment strategies and support the con-
tinued use of EVAR in good risk patients. Our finding
that operative mortality and AAA related death were
significantly reduced in patients treated with EVAR
compared to surveillance supports its use in selected
patientswith small aneurysmsandcalls for a confirming
prospective, randomized trial.
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